SCHEMBL744430

SCHEMBL744430

O=S(=O)(c1ccccc1Cl)N1CCC2(CCN(c3ccc(OC(F)(F)F)cc3)C2)CC1

nearest known ligand 0.68

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LIPE Q05469 12/20 0.68
CYP1A2 P05177 4/20 0.46
CYP3A4 P08684 4/20 0.46
ALDH1A1 P00352 3/20 0.46
CYP2C9 P11712 3/20 0.46
CYP2C19 P33261 3/20 0.46
CYP2D6 P10635 2/20 0.46
TSHR P16473 2/20 0.46
CNR2 P34972 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
EPHX2 P34913 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
USP2 O75604 2/20 0.44
CCR1 P32246 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL746711 0.81 CYP2C9 (0.48) LIPECYP1A2CYP3A4ALDH1A1CYP2C9
SCHEMBL744705 0.81 CYP1A2 (0.47) LIPECYP1A2CYP3A4ALDH1A1CYP2C9
SCHEMBL745848 0.81 LIPE (1.00) LIPE
SCHEMBL744989 0.81 CYP3A4 (0.57) LIPECYP1A2CYP3A4ALDH1A1CYP2C9
SCHEMBL746672 0.81 CYP3A4 (0.73) CYP1A2CYP3A4ALDH1A1CYP2C9CYP2C19
SCHEMBL745454 0.81 CYP1A2 (0.54) LIPECYP1A2CYP3A4ALDH1A1CYP2C9
SCHEMBL745542 0.80 CYP2C9 (0.52) LIPECYP1A2CYP3A4ALDH1A1CYP2C9
SCHEMBL745746 0.80 CYP3A4 (0.58) CYP1A2CYP3A4ALDH1A1CYP2C9CYP2C19
SCHEMBL746534 0.79 CYP3A4 (0.48) LIPECYP1A2CYP3A4ALDH1A1CYP2C9
SCHEMBL746619 0.79 LIPE (0.47) LIPECYP1A2CYP3A4ALDH1A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2430023-A1 AZACYCLIC SPIRODERIVATIVES AS HSL INHIBITORS F. Hoffmann-La Roche AG (CH) 2012-03-21 EP disclosed
WO-2010130665-A1 AZACYCLIC SPIRODERIVATIVES AS HSL INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2010-11-18 WO disclosed